DocGo reported second quarter EPS of $-0.160, $0.06 worse than the analyst estimate of $-0.100. Revenue for the quarter came in at $73.42M versus the consensus estimate of $75.4M. The company sees FY 2026 revenue of $305.000M-$310.000M, close to the analyst consensus of $305.100M. DocGo’s stock price closed at $0.71, up 18.000% in the last 3 months but down -57.740% in the last 12 months. According to InvestingPro, DocGo’s Financial Health score is 'fair performance'.
Markets
Markets